Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo

Lin Zhang; Yanhong Hou; Chunmei Li; Haorun Liu; Yujing Wang

doi:10.1016/j.ajg.2022.06.005

Q2 2022

Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo

Lin Zhang · Yanhong Hou · Chunmei Li · Haorun Liu · Yujing Wang

10.1016/j.ajg.2022.06.005 385 Views 5 Citations

Citations

385

Views

Abstract not available for this publication.

Cite this Article (APA)

Lin, Z., Yanhong, H., Chunmei, L., Haorun, L., Yujing, W. (2022). Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2022.06.005